Multiple Sclerosis and the Accumulation of Iron in the Basal Ganglia: Quantitative Assessment of Brain Iron Using MRI T2 Relaxometry

被引:48
作者
Burgetova, A. [1 ]
Seidl, Z. [1 ,3 ]
Krasensky, J. [1 ]
Horakova, D. [2 ]
Vaneckova, M. [1 ]
机构
[1] Charles Univ Prague, Gen Teaching Hosp, Fac Med 1, Dept Radiol, CZ-12808 Prague 2, Czech Republic
[2] Charles Univ Prague, Gen Teaching Hosp, Fac Med 1, Dept Neurol, CZ-12808 Prague 2, Czech Republic
[3] Coll Med, Prague, Czech Republic
关键词
Multiple sclerosis; Iron accumulation; Magnetic resonance imaging; T-2; relaxometry; MATTER T2 HYPOINTENSITY; GRAY-MATTER; ATROPHY; AGE; NEURODEGENERATION; INHIBITION; METABOLISM; SIGNAL;
D O I
10.1159/000279305
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The aim of this work was to quantify the accumulation of iron in the basal ganglia in multiple sclerosis (MS) patients and in a control group, and to investigate the relationship between iron accumulation and other parameters assessed in MS, i.e. lesion load (LL) and brain parenchymal fraction (BPF). Magnetic resonance imaging T-2 relaxometry was used for the measurement. 970 patients with clinically definite MS and 117 controls were examined. Patients were divided into three subgroups according to LL and BPF. This work provides quantitative evidence of increased iron accumulation in the basal ganglia in MS patients in comparison to healthy controls. We also found that in the subgroup with small LL value, iron accumulation is higher than in the subgroup with large LL value. The hypothesis of a neurodegenerative component of MS is supported by the changes in iron content in the brain. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:136 / 143
页数:8
相关论文
共 36 条
[1]   T2 hypointensity in the deep gray matter of patients with multiple sclerosis - A quantitative magnetic resonance imaging study [J].
Bakshi, R ;
Benedict, RHB ;
Bermel, RA ;
Caruthers, SD ;
Puli, SR ;
Tjoa, CW ;
Fabiano, AJ ;
Jacobs, L .
ARCHIVES OF NEUROLOGY, 2002, 59 (01) :62-68
[2]   Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients [J].
Bakshi, R ;
Dmochowski, J ;
Shaikh, ZA ;
Jacobs, L .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 185 (01) :19-26
[3]   MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation [J].
Bakshi, R ;
Shaikh, ZA ;
Janardhan, V .
NEUROREPORT, 2000, 11 (01) :15-21
[4]  
Bakshi Rohit, 2005, NeuroRx, V2, P277, DOI 10.1007/BF03206672
[5]   Increased basal ganglia iron levels in Huntington disease [J].
Bartzokis, G ;
Cummings, J ;
Perlman, S ;
Hance, DB ;
Mintz, J .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :569-574
[6]   Brain ferritin iron may influence age- and gender-related risks of neurodegeneration [J].
Bartzokis, George ;
Tishler, Todd A. ;
Lu, Po H. ;
Villablanca, Pablo ;
Altshuler, Lori L. ;
Carter, Michele ;
Huang, Danny ;
Edwards, Nancy ;
Mintz, Jim .
NEUROBIOLOGY OF AGING, 2007, 28 (03) :414-423
[7]   Iron metabolism in parkinsonian syndromes [J].
Berg, Daniela ;
Hochstrasser, Helmine .
MOVEMENT DISORDERS, 2006, 21 (09) :1299-1310
[8]   Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity [J].
Bermel, RA ;
Puli, SR ;
Rudick, RA ;
Weinstock-Guttman, B ;
Fisher, E ;
Munschauer, FE ;
Bakshi, R .
ARCHIVES OF NEUROLOGY, 2005, 62 (09) :1371-1376
[9]   Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study [J].
Bermel, RA ;
Innus, MD ;
Tjoa, CW ;
Bakshi, R .
NEUROREPORT, 2003, 14 (03) :335-339
[10]   INHIBITION OF AUTOIMMUNE NEUROPATHOLOGICAL PROCESS BY TREATMENT WITH AN IRON-CHELATING AGENT [J].
BOWERN, N ;
RAMSHAW, IA ;
CLARK, IA ;
DOHERTY, PC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (05) :1532-1543